What are the causes of axillary lymphadenopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Axillary Lymphadenopathy

Axillary lymphadenopathy is most commonly benign, but when malignancy is present, breast cancer is the leading cause, followed by lymphoma and other metastatic diseases. 1

Benign Causes

Infectious and Inflammatory Processes

  • Reactive lymphadenopathy from infections is the most common benign etiology 1
  • Tuberculosis can present as unilateral axillary lymphadenopathy, particularly in patients with latent TB or immunosuppression 2
  • Vaccine-associated lymphadenopathy, especially after COVID-19 vaccination, occurs in 0.3-53% of vaccinated individuals and can persist for more than 100 days 3
  • Acute infections causing reactive changes 4

Autoimmune and Systemic Diseases

  • Rheumatoid arthritis and other collagen vascular diseases 1, 5
  • Sarcoidosis 5
  • Dermatopathic lymphadenopathy from skin conditions 6
  • Amyloidosis 4

Breast Implant-Related

  • Silicone adenitis from ruptured breast implants, where free silicone migrates to axillary lymph nodes and produces a characteristic "snowstorm" appearance on ultrasound 1
  • Benign lymphadenopathy associated with intact breast implants 1

Other Benign Causes

  • Nonspecific benign lymphadenopathy (most frequent benign diagnosis at 29% in screening populations) 5
  • Healed granulomatous disease 4

Malignant Causes

Breast Cancer

  • Metastatic breast cancer is the most common malignant cause when cancer is identified in axillary nodes 1
  • Accounts for 26% of axillary lymphadenopathy cases in screening populations 5
  • Can present as occult breast cancer with axillary metastases but no detectable breast primary (T0 N1b presentation), occurring in less than 1% of breast cancers 1, 7
  • In patients with isolated axillary masses and confirmed cancer, occult breast cancer was found in 9 of 17 cases, with 5 in the contralateral breast 1

Hematologic Malignancies

  • Chronic lymphocytic leukemia or well-differentiated lymphocytic lymphoma (17% of lymphadenopathy cases) 5
  • Non-Hodgkin's lymphoma (found in 6 of 15 recalled screening patients with isolated lymphadenopathy) 4
  • Other lymphomas 1
  • Leukemia 4

Metastatic Disease from Non-Breast Primaries

  • Metastatic carcinoma from unknown primary sites 4, 5
  • Metastatic disease from known non-breast primary tumors 5

Clinical Context and Risk Stratification

Imaging Characteristics Associated with Malignancy

  • Lymph node length >33 mm (specificity 97%, sensitivity 31% for malignancy) 5
  • Ill-defined or spiculated margins 5
  • Replacement of fatty hilum 4
  • Rounded shape rather than oval 4
  • Intranodal microcalcifications 5

High-Risk Scenarios

  • When axillary lymphadenopathy is detected with an additional mammographic abnormality, 75% show malignancy 4
  • In screening-detected isolated lymphadenopathy without known underlying cause, 52-62% have underlying malignancy 4

Important Caveats

  • Most benign and malignant lymph nodes cannot be distinguished mammographically, despite statistical associations 5
  • The differential diagnosis varies significantly based on whether lymphadenopathy is unilateral versus bilateral 1
  • Bilateral axillary lymphadenopathy more commonly suggests systemic processes including infections, inflammatory conditions, or hematologic malignancies 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vaccine-associated axillary lymphadenopathy with a focus on COVID-19 vaccines.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2025

Research

Axillary lymph nodes: mammographic, pathologic, and clinical correlation.

AJR. American journal of roentgenology, 1997

Guideline

Management of Benign Axillary Lymphadenopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut Curie.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.